drugset

drugset / Trial / NCT05557604

Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer

NCT05557604 ↗

Phase 2 Recruiting 146 enrolled Regina Elena Cancer Institute

RandomizedParallel-groupSingle-blindSupportive care

Summary

This is a prospective, open, randomized phase II trial.

Timeline

Start: 2021-02-02
Primary completion: 2024-02-02
Completion: 2027-02-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Decapeptyl	Unknown	—	—

Indications